Skip to content

SNDXSYNDAX PHARMACEUTICALS INC

CUSIP 87164F105 · common stock

1 tracked investor held SYNDAX PHARMACEUTICALS INC (SNDX) at the end of Q3 2026, worth $2.5M. The largest holder was Torray Funds, with 0.3% of its portfolio.

Holders · Q3 2026
1
New holders
0
Value held
$2.5M
Quarter-end price (est.)
$18.80

Investors holding SNDX · Q3 2026

InvestorWeightSharesValueChange
Torray Funds
Torray Investment Partners LLC
0.33%133,654$2.5MREDUCE-0.1%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026100$2.5M$18.80
Q2 2026101$2.9M$21.86
Q1 2026200$2.9M$23.36
Q4 2025200$2.3M$21.01